Protection against MIS-C outweighs the risk of myocarditis after Covid-19 vaccination in children.

Ital J Pediatr

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genova, Genoa, Italy.

Published: August 2022

From March 2020 to July 2022, in Liguria region (North-West Italy) incidence of MIS-C among pediatric patients infected by SARS-CoV-2 was 38.7/100.000, which is higher than that of myocarditis after COVID-19 vaccination. In our opinion severity of MIS-C-related cardiac disease outweigh the risk of myocarditis after COVID-19 vaccine.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354361PMC
http://dx.doi.org/10.1186/s13052-022-01335-1DOI Listing

Publication Analysis

Top Keywords

myocarditis covid-19
12
risk myocarditis
8
covid-19 vaccination
8
protection mis-c
4
mis-c outweighs
4
outweighs risk
4
vaccination children
4
children march
4
march 2020
4
2020 july
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!